Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidepressants on Stress-Responsive Systems
DRKS00000008Phase 3Completed
- Sponsor
- Central Institute of Mental Health
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirtazapine, venlafaxine in major depressive episode (MDE), recurrent depressive disorder (RDD), sponsored by Central Institute of Mental Health. Started Sep 2008; status: completed.
02
Drugs
mirtazapinevenlafaxine
03
Conditions
major depressive episode (MDE)recurrent depressive disorder (RDD)
Beyond the preview
Go deeper on DRKS00000008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000008.